Acetaminophen market seen reaching $11.79 billion by 2030

The Business Research Company projects the global acetaminophen market will grow from $9.23 billion in 2025 to $11.79 billion by 2030, driven by rising fever and flu cases, OTC demand and expanding homecare use. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Acetaminophen remains a core over-the-counter treatment for pain and fever, so demand trends track broader shifts in self-care, flu activity and access to home treatment. - The market’s projected 5.1% CAGR through 2030 signals steady growth for manufacturers, retailers and distributors serving both consumer and healthcare channels.

What happened: - The Business Research Company said the global acetaminophen market is expected to rise from $9.23 billion in 2025 to $9.67 billion in 2026. - The market is forecast to reach $11.79 billion by 2030, implying a 5.1% CAGR over the period. - The report was released June 30, 2026, from London. - The company also published a free sample of the report and the full acetaminophen market report.

The details: - The market’s recent growth has been supported by higher rates of fever and pain-related illnesses, broader availability of OTC products, rising healthcare spending in developing countries, expanding retail pharmacy networks and more self-medication. - The report says future growth will be supported by demand for advanced drug delivery systems, more pharmaceutical manufacturing investment, an aging population with chronic pain, broader homecare access and more targeted products for pediatric and elderly patients. - Key trends include stronger preference for OTC pain relief, more interest in pediatric acetaminophen, wider use of extended-release formulations, better consumer education on safe dosage and higher demand for oral and liquid forms. - Acetaminophen is described as a pain and fever medicine that works through brain chemical pathways that affect pain sensation and body temperature. - The report says acetaminophen is commonly used within recommended dosages and is valued for safety and efficacy in mild to moderate symptoms. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - North America held the largest share of the market in 2025. - Asia-Pacific is projected to post the fastest growth over the forecast period.

Between the lines: - The forecast reflects more than seasonal flu demand. It also points to structural tailwinds from aging populations, homecare adoption and consumer willingness to treat minor conditions without a prescription. - The emphasis on pediatric, elderly and liquid formulations suggests suppliers are chasing convenience and narrower patient segments, not just broad OTC volume. - The market could remain resilient because acetaminophen sits at the intersection of low-cost self-care and recurring public-health need.

What's next: - The report says growth should continue through 2030 as OTC use, homecare treatment and targeted formulations expand. - The Business Research Company said its 2026 market reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market-hotspots infographics and updated trend analysis. - The company listed Saumya Sahay as a contact for expert inquiries and provided regional phone numbers and the email marketing@tbrc.info. - The company also shared social links on LinkedIn, Facebook and X/Twitter.